- Merck (MRK) Q2 earnings report 2023 CNBC
- Merck posts narrower-than-expected loss as sales of top drugs beat Street estimates Yahoo News
- Merck Posts Narrower Q2 Loss, Lifts Sales Forecast On Keytruda Boost TheStreet
- Merck Stock: Sales Outplays Covid Decline, But Comes In With Per-Share Losses Investor’s Business Daily
- Merck Non-GAAP EPS of -$2.06, revenue of $15B beats by $560M (NYSE:MRK) Seeking Alpha
- View Full Coverage on Google News
Add Comment